BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3838497)

  • 1. Tumorigenicity of 5-methylchrysene dihydrodiols and dihydrodiol epoxides in newborn mice and on mouse skin.
    Hecht SS; Radok L; Amin S; Huie K; Melikian AA; Hoffmann D; Pataki J; Harvey RG
    Cancer Res; 1985 Apr; 45(4):1449-52. PubMed ID: 3838497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-initiating activity of dihydrodiols formed metabolically from 5-methylchrysene.
    Hecht SS; Rivenson A; Hoffmann D
    Cancer Res; 1980 May; 40(5):1396-9. PubMed ID: 7370979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumorigenic activity of the 4,5- and 9,10-dihydrodiols of benzo[j]fluoranthene and their syn- and anti-diol epoxides in newborn mice.
    LaVoie EJ; He ZM; Wu Y; Meschter CL; Weyand EH
    Cancer Res; 1994 Feb; 54(4):962-8. PubMed ID: 8313387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition by a peri-fluorine atom of 1,2-dihydrodiol formation as a basis for the lower tumorigenicity of 12-fluoro-5-methylchrysene than of 5-methylchrysene.
    Amin S; Camanzo J; Hecht SS
    Cancer Res; 1984 Sep; 44(9):3772-8. PubMed ID: 6547637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of bay-region methyl group on formation of 5-methylchrysene dihydrodiol epoxide:DNA adducts in mouse skin.
    Melikian AA; LaVoie EJ; Hecht SS; Hoffmann D
    Cancer Res; 1982 Apr; 42(4):1239-42. PubMed ID: 7060000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative metabolic activation in mouse skin of the weak carcinogen 6-methylchrysene and the strong carcinogen 5-methylchrysene.
    Amin S; Huie K; Melikian AA; Leszczynska JM; Hecht SS
    Cancer Res; 1985 Dec; 45(12 Pt 1):6406-42. PubMed ID: 4063989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rates of hydrolysis and extents of DNA binding of 5-methylchrysene dihydrodiol epoxides.
    Melikian AA; Leszczynska JM; Amin S; Hecht SS; Hoffmann D; Pataki J; Harvey RG
    Cancer Res; 1985 May; 45(5):1990-6. PubMed ID: 3986755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the major adducts formed by reaction of 5-methylchrysene anti-dihydrodiol-epoxides with DNA in vitro.
    Melikian AA; Amin S; Hecht SS; Hoffmann D; Pataki J; Harvey RG
    Cancer Res; 1984 Jun; 44(6):2524-9. PubMed ID: 6547075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumorigenicity of dihydrodiols and diol-epoxides of benz[c]acridine in newborn mice.
    Chang RL; Levin W; Wood AW; Kumar S; Yagi H; Jerina DM; Lehr RE; Conney AH
    Cancer Res; 1984 Nov; 44(11):5161-4. PubMed ID: 6488176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for bay region activation of chrysene 1,2-dihydrodiol to an ultimate carcinogen.
    Levin W; Wood AW; Chang RL; Yagi H; Mah HD; Jerina DM; Conney AH
    Cancer Res; 1978 Jun; 38(6):1831-4. PubMed ID: 647691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumorigenicity in newborn mice of fjord region and other sterically hindered diol epoxides of benzo[g]chrysene, dibenzo[a,l]pyrene (dibenzo[def,p]chrysene), 4H-cyclopenta[def]chrysene and fluoranthene.
    Amin S; Desai D; Dai W; Harvey RG; Hecht SS
    Carcinogenesis; 1995 Nov; 16(11):2813-7. PubMed ID: 7586203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High tumorigenicity of the 3,4-dihydrodiol of 7-methylbenz[c]acridine on mouse skin and in newborn mice.
    Chang RL; Levin W; Wood AW; Shirai N; Ryan AJ; Duke CC; Jerina DM; Holder GM; Conney AH
    Cancer Res; 1986 Sep; 46(9):4552-5. PubMed ID: 3731110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of 6-nitro substitution on 5-methylchrysene tumorigenicity, mutagenicity and metabolism.
    el-Bayoumy K; Amin S; Hecht SS
    Carcinogenesis; 1986 Apr; 7(4):673-6. PubMed ID: 3509952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High stereoselectivity among the optical isomers of the diastereomeric bay-region diol-epoxides of benz(a)anthracene in the expression of tumorigenic activity in murine tumor models.
    Levin W; Chang RL; Wood AW; Yagi H; Thakker DR; Jerina DM; Conney AH
    Cancer Res; 1984 Mar; 44(3):929-33. PubMed ID: 6692415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinogenic metabolites of 5-methylchrysene.
    Pataki J; Lee H; Harvey RG
    Carcinogenesis; 1983; 4(4):399-402. PubMed ID: 6839413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumorigenicity of optical isomers of the diastereomeric bay-region 3,4-diol-1,2-epoxides of benzo(c)phenanthrene in murine tumor models.
    Levin W; Chang RL; Wood AW; Thakker DR; Yagi H; Jerina DM; Conney AH
    Cancer Res; 1986 May; 46(5):2257-61. PubMed ID: 3697970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing effect of a bay region methyl group on tumorigenicity in newborn mice and mouse skin of enantiomeric bay region diol epoxides formed stereoselectively from methylchrysenes in mouse epidermis.
    Hecht SS; Amin S; Huie K; Melikian AA; Harvey RG
    Cancer Res; 1987 Oct; 47(20):5310-5. PubMed ID: 3652037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative metabolism and DNA binding of 6-nitro-5-methylchrysene and 5-methylchrysene.
    Shiue GH; el-Bayoumy K; Hecht SS
    Carcinogenesis; 1987 Sep; 8(9):1327-31. PubMed ID: 3621469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Methylchrysene metabolism in mouse epidermis in vivo, diol epoxide--DNA adduct persistence, and diol epoxide reactivity with DNA as potential factors influencing the predominance of 5-methylchrysene-1,2-diol-3,4-epoxide--DNA adducts in mouse epidermis.
    Melikian AA; LaVoie EJ; Hecht SS; Hoffmann D
    Carcinogenesis; 1983; 4(7):843-9. PubMed ID: 6872139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of 6-methylchrysene-1,2-diol-3,4-epoxides and comparison of their mutagenicity to 5-methylchrysene-1,2-diol-3,4-epoxides.
    Amin S; Huie K; Hecht SS; Harvey RG
    Carcinogenesis; 1986 Dec; 7(12):2067-70. PubMed ID: 3779900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.